Gritstone, Gilead Partner To Develop Therapeutic HIV Vaccine

Deal Closely Follows COVID-19 Vaccine Effort

 
• By Alaric DeArment
  
HIV Vaccine
Gritstone and Gilead are partnering to develop a therapeutic HIV vaccine. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip